Malignant Large Intestinal Neoplasm — Trials

Malignant Large Intestinal Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

7,502 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 1,622
Recruiting: 914
Ph III recruiting: 106
Growth YoY: +12.3%
Industry share: 22%
Top sponsor: Fudan University
Termination share: 25.6%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (742)

clinicaltrialsPublishedShowing 1–2 of 2 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT06653010	Universal CAR-T Cells (REVO-UWD-01) for Metastatic Colorectal Cancer(Wondercel-UWD1)	suspended	Early Phase 1	30	Wondercel Biotech (ShenZhen)INDUSTRY	1	May 7, 2026	clinicaltrials
NCT06675513	Autologous CAR-T Cells (WD-01) for Metastatic Colorectal Cancer	suspended	Early Phase 1	30	Wondercel Biotech (ShenZhen)INDUSTRY	1	May 7, 2026	clinicaltrials